Skip to Main Content

Paper Details

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
Nat Med
43
2022
Circulating tumor, Circulating tumor DNA, PIK3CA, RICTOR, advanced non-small-cell lung cancer, ctDNA, non-small-cell lung cancer, patients, tumor, tumor DNA
Author NameAffiliation
Randy YehMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Debyani ChakravartyMemorial Sloan Kettering Cancer Center
Ritika KundraMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center
Gregory J RielyCornell University
Mithat GonenMemorial Sloan Kettering Cancer Center
Daniel R GomezMemorial Sloan Kettering Cancer Center
Daniel R GomezCornell University
Alexander DrilonMemorial Sloan Kettering Cancer Center
Alexander DrilonCornell University
Howard I ScherMemorial Sloan Kettering Cancer Center
Howard I ScherCornell University
Michael F BergerMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Marc LadanyiCornell University
Ronglai ShenMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoCornell University
Charles M RudinMemorial Sloan Kettering Cancer Center
Charles M RudinCornell University
  • 1 - 22

Datasets

Release 1.2